NCT00457561已完成不适用
Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis
Hamamatsu University0 个研究点开始时间: 2007年4月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
Decreased body fat mass, possibly mediated through the effects of elevated serum adiponectin levels, may be associated with requirements for higher recombinant human erythropoietin doses and a subsequent worse prognosis in patients beginning hemodialysis.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who started hemodialysis therapy from August 2000 to May 2001 in 11 dialysis centers in the Shizuoka prefecture area, and who survived for more than 3 months after the start of hemodialysis.
排除标准
- •Nothing particular.
研究者
相似试验
终止
不适用
Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning HDRenal DialysisNCT00457535Hamamatsu University
已完成
不适用
Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)Renal DialysisNCT00308698Hamamatsu University
已完成
不适用
The effect of erythropoietin in reduction of tissue–reperfusion injury after coronary artery baypass graftTissue-reperfusiuon injury.Atherosclerotic heart diseaseIRCT138809102799N1Deputy of Research and Technology of Mazandarn University of Medical Sciences50
已完成
不适用
Calorie Restriction in Multiple Sclerosis PatientsMultiple SclerosisNCT02411838Washington University School of Medicine17
已完成
2 期
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial InfarctionMyocardial InfarctionNCT00367991Yale University44